Search
Filters
Clear All
  • 12
  • 45
  • 1
  • 565

Phase

  • 8
  • 9
  • 41
  • 6
  • 61
  • 5
  • 486
  • 551
  • 275
  • 613
  • 10

Found 623 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

HAVE YOU RECENTLY TESTED POSITIVE FOR COVID? Help Us Test a New Treatment for Covid!

HAVE YOU RECENTLY TESTED POSITIVE FOR COVID? Help Us Test a New Treatment for Covid!

J
James Chmiel
M
Mike Davis
18 years - 60 years
Accepts healthy volunteer
All genders
Researchers at Indiana University School of Medicine are researching a nasal treatment for COVID-19. We are looking for people with a recent onset of mild COVID-19 symptoms and a positive COVID-19 test in the last few days to come for a 2 hour visit at Riley Hospital for Children to help …
Check Eligibility
VOLUNTEERS AGES 21-26 NEEDED FOR ALCOHOL AND BRAIN IMAGING STUDY!

VOLUNTEERS AGES 21-26 NEEDED FOR ALCOHOL AND BRAIN IMAGING STUDY!

D
David Kareken, PhD
21 years - 27 years
Accepts healthy volunteer
All genders
Do you drink alcohol? If yes, we want to learn about your brain activity! Researchers at the IU School of Medicine are looking for volunteers aged 21-27 to participate in an alcohol and brain imaging study.Interested potential participants must complete one 3 hour in-person screening. Following the in-person screening, qualified participants in …
Learn More

Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations

A
Anita Turk, MD
18 years or above
All genders
Phase 2
Interventional
What is the purpose of this study?This phase II trial studies whether adding pembrolizumab to olaparib (standard of care) works better than olaparib alone in treating patients with pancreatic cancer with germline BRCA1 or BRCA2 mutations that has spread to other places in the body (metastatic). BRCA1 and BRCA2 are …
Learn More

Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)

L
Lisa Landrum, MD, PhD, MS
18 years or above
Female
Phase 3
Interventional
What is the purpose of this study?This is a Phase 3, multicenter, open-label, randomized study of nemvaleukin in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, …
Learn More

A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

B
Bryan Schneider, MD
18 years - 100 years
All genders
Phase 3
Interventional
What is the purpose of this study?This Phase III, randomized, open-label, multicenter study will evaluate the efficacy andy of giredestrant plus everolimus compared with the physician's choice of endocrineherapy plus everolimus in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer …
Learn More

Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer (PERSEVERE)

B
Bryan Schneider, MD
18 years or above
All genders
Phase 2
Interventional
What is the purpose of this study?This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease afterve therapy will be assigned to 1 of 3 Arms based on plasma ctDNA positivity and genomic marker(s). THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, …
Learn More

PSMA-PET to Guide Prostatectomy

C
Clinton Bahler, MD
40 years - 80 years
Male
Phase 2/3
Interventional
What is the purpose of this study?This study will randomize subjects to either standard of care MRI prior to radical prostatectomy or standard of care MRI and the PSMA (prostate specific membrane antigen) PET scan prior to radical prostatectomy to see if this scan will be helpful in detecting prostate …
Learn More

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (ADEPT)

T
Tarah Ballinger, MD
18 years or above
All genders
Phase 2
Interventional
What is the purpose of this study?This research study is studying a combination of HER2-directed therapies (trastuzumab anduzumab) and hormonal therapy as a treatment after surgery for hormone receptor positive breast cancer. The study drugs involved in this study are: A combination of trastuzumab and pertuzumab given as an injection …
Learn More
Adults With or Without Chronic Kidney Disease Needed for CBD Study

Adults With or Without Chronic Kidney Disease Needed for CBD Study

M
Michael Eadon, MD
18 years - 75 years
Accepts healthy volunteer
All genders
Phase 1
Have you ever wondered about the safety of medicinal CBD?  Join our study!  What is this study about?The goal of this study is to assess the safety of CBD with tacrolimus, an agent taken by transplant patients to prevent organ rejection. This study seeks to understand the interaction between CBD and …
Check Eligibility

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

A
Angela M. Richardson, MD, PhD
18 years or above
All genders
Phase 3
Interventional
What is the purpose of this study?This trial will be a randomized controlled study comparing the efficacy and safety ofve radiation therapy using GammaTilesTM (GT) versus SRS 3-4 weeks followingumor resection which is the current standard of care. THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology …
Learn More
11 - 20 of 623